Repatha News - Aug 29, 2022, 03:10 et. Web a strong warning has been issued for evolocumab (repatha) by researchers from spain and canada on. Earlier treatment with repatha resulted in a lower incidence of major cv. Web amgen announces results from two open label extension studies of repatha® (evolocumab). Web new positive phase 3 data for repatha in acs patients who initiated treatment in the acute setting.
Aug 29, 2022, 03:10 et. Web amgen announces results from two open label extension studies of repatha® (evolocumab). Web new positive phase 3 data for repatha in acs patients who initiated treatment in the acute setting. Earlier treatment with repatha resulted in a lower incidence of major cv. Web a strong warning has been issued for evolocumab (repatha) by researchers from spain and canada on.